Investors in Apellis Pharmaceuticals Inc (Symbol: APLS) saw new options begin trading this week, for the May 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...

NASDAQ APLS opened at $19.97 on Thursday. The firm has a market capitalization of $2.51 billion, a price-to-earnings ratio of -9.84 and a beta of 0.85. Apellis Pharmaceuticals has a 52 week low of ...

In this article, we are going to take a look at where Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) stands against other most oversold healthcare stocks to buy now. Healthcare costs and spending ...

“I want to thank Doctor Pack for her service to the APLS organization, and I appreciate that she recognizes the need for her resignation,” Minton said. “However, I believe the APLS needs an ...

Apellis Pharmaceuticals APLS announced that the FDA has accepted its supplemental new drug application (sNDA) seeking the label expansion of Empaveli (pegcetacoplan) for two rare and severe kidney ...

In trading on Monday, shares of Apellis Pharmaceuticals Inc (Symbol: APLS) entered into oversold territory, hitting an RSI reading of 26.7, after changing hands as low as $21.89 per share.